Clinical trial
The Renin-Angiotensin System in Essential Hypertension
NCT00141583 · St George's, University of London, Other · Terminated
Key facts
| NCT number | NCT00141583 |
|---|---|
| Title | The Renin-Angiotensin System in Essential Hypertension |
| Official title | The Renin-Angiotensin System in Essential Hypertension |
| Lead sponsor | St George's, University of London, Other |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Enalapril 20 mg bd, Candesartan 8 mg bd |
| Enrollment | 11 |
| Start date | Apr 1, 2004 |
| Completion | Oct 1, 2006 |
| First posted | Sep 1, 2005 |
| Last update posted | Jun 9, 2015 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: